Bilah Samping Artikel
Isi Artikel Utama
Abstrak
ABSTRAK
Kanker payudara adalah salah satu kanker yang banyak ditemukan di dunia. Makrofag yang dijumpai pada kanker dikenal dengan istilah Tumor Asociated Macrophage (TAM) yang meliputi fenotip makrofag M1 dan M2. Kedua fenotip ini mempunyai fungsi yang berlawanan.
Kata Kunci : Kanker payudara, Makrofag M1, Makrofag M2
Rincian Artikel
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Referensi
- DAFTAR PUSTAKA
- Tjindarbumi D, dan Mangunkusuma R, 2002, Cancer in Indonesia, Present and Future, JpJ Clin Oncol,32 (Supplement 1), 17-21.
- Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL, 2002. Global and regional estimates of cancer mortality and incidences by site: II. Results for the global burden of disease 2000.BMC Cancer, 2(37).
- Sander M, Trump BF, and Tennant RW, 2008, The 20thaspen cancer conference; mechanism of toxicity, carcinogenesis, cancer prevention and cancer therapy, Mol Carcinog, 47(9):707-732.
- Hagedoorn EML, Oldhoff J, Bender W, 1994, Essential oncology for heallth professionals, Van Gurcum, Assen : 53-70.
- Pazdur R, Wagmn LD, Camphausen KA, and Hoskins WJ, 2009, Cancer Management: A Multidiciplinary Approach, 12th edition, CMP Medica: America.
- Antonio Sica, Tiziana Schiopp, Alberto Mantovani, Paola Allavena. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression. Potential targets of anti-cancer therapy. EJC 42 (2006) 717 –727.
- Matsushima K., Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1999;169:1485–90.
- Duyndam MC, Hilhorst MC, Schluper HM. Vascularendothelial growth factor-165 overexpression stimulatesangiogenesis and induces cyst formation and macrophageinfiltration in human ovarian cancer xenografts. Am J Pathol 2002;160:537–48.
- Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23–35.
- Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209–12.
- Moon ML, McNeil LK, Freund GG. 2011. Macrophages make me sick how macrophage activation states influence sickness behavior Psychoneuroendocrinology, 36 : 1431-4
Referensi
DAFTAR PUSTAKA
Tjindarbumi D, dan Mangunkusuma R, 2002, Cancer in Indonesia, Present and Future, JpJ Clin Oncol,32 (Supplement 1), 17-21.
Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL, 2002. Global and regional estimates of cancer mortality and incidences by site: II. Results for the global burden of disease 2000.BMC Cancer, 2(37).
Sander M, Trump BF, and Tennant RW, 2008, The 20thaspen cancer conference; mechanism of toxicity, carcinogenesis, cancer prevention and cancer therapy, Mol Carcinog, 47(9):707-732.
Hagedoorn EML, Oldhoff J, Bender W, 1994, Essential oncology for heallth professionals, Van Gurcum, Assen : 53-70.
Pazdur R, Wagmn LD, Camphausen KA, and Hoskins WJ, 2009, Cancer Management: A Multidiciplinary Approach, 12th edition, CMP Medica: America.
Antonio Sica, Tiziana Schiopp, Alberto Mantovani, Paola Allavena. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression. Potential targets of anti-cancer therapy. EJC 42 (2006) 717 –727.
Matsushima K., Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1999;169:1485–90.
Duyndam MC, Hilhorst MC, Schluper HM. Vascularendothelial growth factor-165 overexpression stimulatesangiogenesis and induces cyst formation and macrophageinfiltration in human ovarian cancer xenografts. Am J Pathol 2002;160:537–48.
Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23–35.
Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209–12.
Moon ML, McNeil LK, Freund GG. 2011. Macrophages make me sick how macrophage activation states influence sickness behavior Psychoneuroendocrinology, 36 : 1431-4